Injective vs Sign — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,76T 24h volume), while Sign trades at Rp156.22 (market cap Rp374,51M, Rp71,67M 24h volume). The key difference: Injective is far larger — about 24805.7× Sign's market cap, and Sign's supply is capped (2,4B / 10B SIGN (24%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Sign for 20 Days on average.
| INJ | SIGN | |
|---|---|---|
Market Cap | Rp9,29T | Rp374,51M |
Volume (24h) | Rp1,76T | Rp71,67M |
Circulating Supply | 100M INJ | 2,4B / 10B SIGN (24%) |
Typical Hold Time | 36 Days | 20 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
SIGN trades at Rp156.745 with a market cap of Rp374.27 million, showing neutral technical signals overall despite a bearish moving average bias. The token's circulating supply is 2.4 million out of a 10 million max, with a 24% circulation rate and average hold time of 20 days. No major protocol updates or ecosystem news were identified recently, keeping fundamental developments limited.
Outlook is cautious due to mixed technical indicators and low liquidity. Key opportunities include potential growth from increased adoption, but risks involve high volatility, limited exchange depth, and regulatory uncertainty in the crypto space. Investors should monitor support at Rp154 and resistance at Rp159 for near-term direction.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Sign is developing global infrastructure for credential verification and token distribution through two main products. The Sign Protocol is an omni-chain attestation protocol that supports digital public infrastructure for governments and serves as a foundational layer for decentralized applications. TokenTable is a smart contract-based platform that streamlines token distribution processes such as airdrops, vesting, and unlocks, allowing for seamless and transparent on-chain management.
Read more on SIGN →